Insider · CIK 0002012715

Nayak Sanjay

Reports to the SEC for 1 company · BEDFORD, MA

sec.gov

Transactions

Companies

Filings

CIK

0002012715

Forms 4 and 5

Insider transactions

17 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-24	OCULOCULAR THERAPEUTIX, INCS Sale	Chief Strategy Officer	SSale	−1,897 sh	$10.78	−$20.4K	326,898
2026-05-26	OCULOCULAR THERAPEUTIX, INCS Sale	Chief Strategy Officer	SSale	−1,858 sh	$8.20	−$15.2K	328,795
2026-02-23	OCULOCULAR THERAPEUTIX, INCS Sale	Chief Strategy Officer	SSale	−1,759 sh	$8.28	−$14.6K	330,653
2026-02-12	OCULOCULAR THERAPEUTIX, INCS Sale	Chief Strategy Officer	SSale	−10.3K sh	$9.04	−$93.5K	332,412
2026-01-02	OCULOCULAR THERAPEUTIX, INCA Award	Chief Strategy Officer	AAward	+64.9K sh	—	—	342,760
2026-01-02	OCULOCULAR THERAPEUTIX, INC · Stock Option (Right to Buy)A Award	Chief Strategy Officer	AAward	+198K sh	—	—	197,650
2025-11-24	OCULOCULAR THERAPEUTIX, INCS Sale	Chief Strategy Officer	SSale	−1,878 sh	$12.04	−$22.6K	277,860
2025-08-25	OCULOCULAR THERAPEUTIX, INCS Sale	Chief Strategy Officer	SSale	−1,885 sh	$12.04	−$22.7K	279,738
2025-05-23	OCULOCULAR THERAPEUTIX, INCS Sale	Chief Strategy Officer	SSale	−1,862 sh	$7.17	−$13.4K	281,623
2025-02-24	OCULOCULAR THERAPEUTIX, INCS Sale	Chief Strategy Officer	SSale	−1,895 sh	$6.84	−$13K	283,485
2025-02-11	OCULOCULAR THERAPEUTIX, INCA Award	Chief Strategy Officer	AAward	+111K sh	—	—	285,380
2025-02-11	OCULOCULAR THERAPEUTIX, INC · Stock Option (Right to Buy)A Award	Chief Strategy Officer	AAward	+334K sh	—	—	334,000
2024-11-25	OCULOCULAR THERAPEUTIX, INCS Sale	Chief Strategy Officer	SSale	−1,814 sh	$9.00	−$16.3K	174,380
2024-08-23	OCULOCULAR THERAPEUTIX, INCS Sale	Chief Strategy Officer	SSale	−1,832 sh	$9.02	−$16.5K	176,194
2024-05-23	OCULOCULAR THERAPEUTIX, INCS Sale	Chief Strategy Officer	SSale	−2,274 sh	$5.84	−$13.3K	178,026
2024-02-22	OCULOCULAR THERAPEUTIX, INCA Award	Chief Strategy Officer	AAward	+80.3K sh	—	—	180,300
2024-02-22	OCULOCULAR THERAPEUTIX, INC · Stock Option (Right to Buy)A Award	Chief Strategy Officer	AAward	+245K sh	—	—	244,550

Recent filings

Accepted (ET)
Aug 264
Nayak Sanjay0001104659-26-101671
SEC(opens sec.gov)
May 284
Nayak Sanjay0001104659-26-067478
SEC(opens sec.gov)
Feb 254
Nayak Sanjay0001104659-26-019802
SEC(opens sec.gov)
Feb 174
Nayak Sanjay0001104659-26-016667
SEC(opens sec.gov)
Jan 64
Nayak Sanjay0001104659-26-001292
SEC(opens sec.gov)
Nov 264
Nayak Sanjay0001104659-25-116425
SEC(opens sec.gov)
Aug 274
Nayak Sanjay0001104659-25-084116
SEC(opens sec.gov)
May 274
Nayak Sanjay0001104659-25-053094
SEC(opens sec.gov)
Feb 264
Nayak Sanjay0001104659-25-017562
SEC(opens sec.gov)
Feb 134
Nayak Sanjay0001104659-25-013153
SEC(opens sec.gov)
Nov 274
Nayak Sanjay0001104659-24-123410
SEC(opens sec.gov)
Aug 274
Nayak Sanjay0001104659-24-093503
SEC(opens sec.gov)
May 284
Nayak Sanjay0001104659-24-065645
SEC(opens sec.gov)
Feb 264
Nayak Sanjay0001104659-24-027724
SEC(opens sec.gov)

Companies

OCULAR THERAPEUTIX, INCChief Strategy OfficerOCUL

Address

C/O OCULAR THERAPEUTIX, INC. 14 CROSBY DRIVE, 3RD FLOOR

BEDFORD, MA, 01730